Skip to main content
. 2018 Mar;95:111–119. doi: 10.1016/j.jclinepi.2017.12.008

Table 1.

Samples sizes required for PROTECTS to have 80% power to detect an effect of 0.25 in patients who consent to treatment, under both cmRCT and pRCT designs

Percentage of patients consenting to trial cmRCT
pRCT
Effect size to be detected (adjusted for consent rate) Patients selected Patients consented Patients in treatment vs. control arms Effect size to be detected Patients invited Patients consented Patients in treatment vs. control arms
100% 0.25 139 139 139 vs. 1167 0.25 504 504 252 vs. 252
90% 0.225 178 160 178 vs. 1128 0.25 560 504 252 vs. 252
80% 0.2 237 190 237 vs. 1069 0.25 630 504 252 vs. 252
70% 0.175 344 241 344 vs. 962 0.25 720 504 252 vs. 252
62% 0.155 653 405 653 vs. 653 0.25 813 504 252 vs. 252
60% <80% power 0.25 840 504 252 vs. 252
50% <80% power 0.25 1008 504 252 vs. 252
40% <80% power 0.25 1260 504 252 vs. 252

Abbreviations: cmRCT, cohort multiple randomized controlled trial; pRCT, pragmatic RCT.